Cita APA

Zabkiewicz, J., Gilmour, M., Hills, R., Vyas, P., Bone, E., Davidson, A., . . . Knapper, S. (2016). The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias. Oncotarget.

Chicago Style Citation

Zabkiewicz, Joanna, Marie Gilmour, Robert Hills, Pares Vyas, Elizabeth Bone, Alan Davidson, Alan Burnett, i Steven Knapper. "The Targeted Histone Deacetylase Inhibitor Tefinostat (CHR-2845) Shows Selective in Vitro Efficacy in Monocytoid-lineage Leukaemias." Oncotarget 2016.

Cita MLA

Zabkiewicz, Joanna, et al. "The Targeted Histone Deacetylase Inhibitor Tefinostat (CHR-2845) Shows Selective in Vitro Efficacy in Monocytoid-lineage Leukaemias." Oncotarget 2016.